Panacea Biotec share news, announcements and annual reports
NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap
Panacea Biotec Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95
Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.
30 Oct: open ₹323.05, high ₹325.95, low ₹311.10
52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,919 Cr1,088th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.30
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −0.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- −2.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 57,86658.2% delivered
Panacea Biotec board and management
45 filed, newest first.
May 2026
30 May · Management
Apr 2026
Mar 2026
30 Mar · Management
Dec 2025
Nov 2025
Jul 2025
31 Jul · Management
Apr 2025
1 Apr · Management
1 Apr · Management
Mar 2025
30 Mar · Management
Feb 2025
14 Feb · Management
14 Feb · Management
Jan 2025
Dec 2024
Nov 2024
13 Nov · Management
Sep 2024
27 Sep · Management
Aug 2024
14 Aug · Management
13 Aug · Management
Apr 2024
Feb 2024
13 Feb · Management
Apr 2022
Mar 2022
Aug 2021
Oct 2020
Dec 2019
11 Dec · Management
11 Dec · Management
Apr 2019
8 Apr · Management
Oct 2018
Aug 2015
21 Aug · Management
Dr. Aditya Narain Saksena, Non Executive Independent Director of the Company has resigned from the directorship of the Company vide his letter dated August 20, 2015 due to his ill health and that of his wife and accordingly he ceased to be director of the Company w.e.f. the close of business hours on August 20, 2015
Jul 2015
Mar 2015
Nov 2014
Sep 2014
Aug 2014
Sep 2010
29 Sep · Management
Mr. Gurmeet Singh, Non-Executive Director has ceased to be the Director of the Company w.e.f. September 25, 2010. The members present at the Annual General Meeting held on September 25, 2010 have decided not to fill the vacancy caused by his retirement by rotation pursuant to Section 256 of the Companies Act, 1956.
Jul 2010
Aug 2009
3 Aug · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Un-Audited Financial Results for the quarter ended June 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on July 30, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2008-09. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2009
27 May · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Audited Financial Results for the year ended March 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on May 27, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2008-09. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
29 Jan · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 29, 2009) regarding the Auditor's observations in their report on the Audited Accounts for the financial year 2007-08. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
29 Jul · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on July 28, 2008) regarding the Auditor's observations in the company's report on the Audited Accounts for the financial year 2007-08. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
28 Jan · Management
Panacea Biotec Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 24, 2008) regarding the Auditor's observations in the company's report on the Audited Accounts for the financial year 2006-07. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.